Show simple item record

dc.contributor.authorZarbock, Aen_US
dc.contributor.authorKoyner, JLen_US
dc.contributor.authorGomez, Hen_US
dc.contributor.authorPickkers, Pen_US
dc.contributor.authorForni, Len_US
dc.contributor.authorADQI groupen_US
dc.date.accessioned2023-07-20T10:37:09Z
dc.date.issued2023-07-03en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/89660
dc.description.abstractSepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to approximately 50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment, and elements of renal recovery that have advanced our ability to detect, prevent, and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction, and management of SA-AKI.en_US
dc.languageengen_US
dc.relation.ispartofNephrol Dial Transplanten_US
dc.subjectacute kidney injuryen_US
dc.subjectbiomarkeren_US
dc.subjectrenal replacement therapyen_US
dc.subjectsepsisen_US
dc.titleSepsis-associated acute kidney injury - treatment standard.en_US
dc.typeArticle
dc.identifier.doi10.1093/ndt/gfad142en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37401137en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record